Fleury S.A. (FLRY3) - Total Assets
Based on the latest financial reports, Fleury S.A. (FLRY3) holds total assets worth R$13.22 Billion BRL (≈ $2.59 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Fleury S.A. (FLRY3) shareholders funds for net asset value and shareholders' equity analysis.
Fleury S.A. - Total Assets Trend (2006–2025)
This chart illustrates how Fleury S.A.'s total assets have evolved over time, based on quarterly financial data.
Fleury S.A. - Asset Composition Analysis
Current Asset Composition (December 2025)
Fleury S.A.'s total assets of R$13.22 Billion consist of 33.4% current assets and 66.6% non-current assets.
| Asset Category | Amount (BRL) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | R$0.00 | 0.2% |
| Accounts Receivable | R$2.00 Billion | 15.1% |
| Inventory | R$180.70 Million | 1.4% |
| Property, Plant & Equipment | R$0.00 | 0.0% |
| Intangible Assets | R$1.54 Billion | 11.6% |
| Goodwill | R$4.44 Billion | 33.6% |
Asset Composition Trend (2006–2025)
This chart illustrates how Fleury S.A.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Fleury S.A. (FLRY3) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Fleury S.A.'s current assets represent 33.4% of total assets in 2025, a decrease from 34.7% in 2006.
- Cash Position: Cash and equivalents constituted 0.2% of total assets in 2025, down from 8.4% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 44.0% of total assets, an increase from 19.0% in 2006.
- Asset Diversification: The largest asset category is goodwill at 33.6% of total assets.
Fleury S.A. Competitors by Total Assets
Key competitors of Fleury S.A. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Eurofins-Cerep SA
PA:ALECR
|
France | €84.58 Million |
|
Inoviq Ltd
AU:IIQ
|
Australia | AU$24.52 Million |
|
Bcal Diagnostics Ltd
AU:BDX
|
Australia | AU$7.17 Million |
|
Imagion Biosystems Ltd
AU:IBX
|
Australia | AU$932.48K |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
Fleury S.A. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.97 | 2.51 | 1.41 |
| Quick Ratio | 1.89 | 2.42 | 1.37 |
| Cash Ratio | 0.00 | 0.01 | 0.00 |
| Working Capital | R$2.18 Billion | R$2.63 Billion | R$558.09 Million |
Fleury S.A. - Advanced Valuation Insights
This section examines the relationship between Fleury S.A.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.73 |
| Latest Market Cap to Assets Ratio | 0.13 |
| Asset Growth Rate (YoY) | 1.2% |
| Total Assets | R$13.22 Billion |
| Market Capitalization | $1.72 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Fleury S.A.'s assets below their book value (0.13x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Fleury S.A.'s assets grew by 1.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Fleury S.A. (2006–2025)
The table below shows the annual total assets of Fleury S.A. from 2006 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | R$13.22 Billion ≈ $2.59 Billion |
+1.21% |
| 2024-12-31 | R$13.06 Billion ≈ $2.56 Billion |
+12.80% |
| 2023-12-31 | R$11.58 Billion ≈ $2.27 Billion |
+48.62% |
| 2022-12-31 | R$7.79 Billion ≈ $1.53 Billion |
+28.29% |
| 2021-12-31 | R$6.07 Billion ≈ $1.19 Billion |
+10.14% |
| 2020-12-31 | R$5.51 Billion ≈ $1.08 Billion |
+8.20% |
| 2019-12-31 | R$5.10 Billion ≈ $1.00 Billion |
+30.33% |
| 2018-12-31 | R$3.91 Billion ≈ $767.30 Million |
+10.86% |
| 2017-12-31 | R$3.53 Billion ≈ $692.13 Million |
+17.35% |
| 2016-12-31 | R$3.01 Billion ≈ $589.80 Million |
-6.19% |
| 2015-12-31 | R$3.20 Billion ≈ $628.73 Million |
-0.17% |
| 2014-12-31 | R$3.21 Billion ≈ $629.81 Million |
-0.04% |
| 2013-12-31 | R$3.21 Billion ≈ $630.09 Million |
+17.27% |
| 2012-12-31 | R$2.74 Billion ≈ $537.28 Million |
-3.30% |
| 2011-12-31 | R$2.83 Billion ≈ $555.63 Million |
+113.21% |
| 2010-12-31 | R$1.33 Billion ≈ $260.61 Million |
+5.73% |
| 2009-12-31 | R$1.26 Billion ≈ $246.48 Million |
+103.67% |
| 2008-12-31 | R$616.76 Million ≈ $121.02 Million |
+21.90% |
| 2007-12-31 | R$505.94 Million ≈ $99.27 Million |
+55.14% |
| 2006-12-31 | R$326.11 Million ≈ $63.99 Million |
-- |
About Fleury S.A.
Fleury S.A., together with its subsidiaries, provides diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides health management services, such as telemedicine; orthopedic medicine services; laboratory support; toxicological exam; preventive, integrated solutions, and cli… Read more